Francis J. Martin

Consultant at 20/20 HealthCare Partners LLC

Francis J. Martin

Francis J. Martin

Consultant at 20/20 HealthCare Partners LLC

Overview
Career Highlights

Cappella, Inc.
Corindus, Inc.
NMT Medical, Inc.

RelSci Relationships

120

Number of Boards

5

Birthday

1937

Age

81

Relationships
RelSci Relationships are individuals Francis J. Martin likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer at Arch Therapeutics, Inc.

Relationship likelihood: Strong

Former President & Chief Executive Officer at NMT Medical, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Cappella, Inc.

Relationship likelihood: Strong

Professor at Harvard University

Relationship likelihood: Strong

Chief Executive Officer & Founder at SkinHealth, Inc.

Relationship likelihood: Strong

Director at Kenney Manufacturing Company

Relationship likelihood: Strong

Senior Partner at 4D Innovative Capital International Ltd.

Relationship likelihood: Strong

Professor at Boston University - College of Engineering

Relationship likelihood: Strong

Former Partner at PolyTechnos Venture-Partners GmbH

Relationship likelihood: Strong

Former Chief Executive Officer & Director at Cappella, Inc.

Relationship likelihood: Strong

Paths to Francis J. Martin
Potential Connections via
Relationship Science
You
Francis J. Martin
Consultant at 20/20 HealthCare Partners LLC
Education
Undergraduate Degree

Boston College is one of the nation's best and most selective universities, with U.S. News & World Report ranking Boston College 31st among national universities, and Forbes ranking it 26th in its 2012 America's Best Colleges listing. Boston College confers more than 4,000 degrees annually in more than 50 fields of study through eight schools and colleges. Faculty members are committed to both teaching and research having earned nearly $60 million in research grants in the last year alone. The University has made a major commitment to academic excellence. As part of its Strategic Plan, Boston College is in the process of adding 100 new faculty positions, expanding faculty and graduate research, increasing student financial aid to more than $128 million annually, and widening opportunities in key undergraduate programs, such as international study, internships and student formation. Boston College has experienced tremendous growth in recent years, including a 75 percent increase in undergraduate applications over the past decade, to more than 34,000 for the 2,250 seats in its freshman class. During the same period, an increase in voluntary giving from alumni has helped to move the University's endowment to approximately $1.9 billion. Boston College students have also earned more than 200 prestigious academic scholarships over the past decade, including 2 Rhodes Scholarships, 4 Marshalls, 9 Goldwaters and 162 Fulbright grants.

Memberships
Member
Current

American Heart Association (New York) is an American private company located in New York, NY. The firm provides public health educational services.

Career History
Consultant
Current

20/20 HealthCare Partners (20/20HCP) provides equity financing for promising growth businesses as well as for buyouts or recapitalizations of established companies specializing in the medical technology. They work with management to streamline product development, regulatory approval and market penetration. 20/20HCP strives to expedite the product development cycle, shorten the time to market and increase company value for further investment, buyout, public offering or other exit.20/20HCP focuses specifically on diagnostic imaging and image enhancement and the evolution of diagnostic imaging and personalized medicine. Funding may include initial pre-seed funding, funding of early-stage established companies and funding of mature companies. 20/20 HCP makes direct investments and lead investments. They provide, assistance with strategic alliances and company reviews, sourcing of growth capital and Board of Director level advice.

Executive Chairman
Tenure Unconfirmed

Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA.

Chief Executive Officer
2007 - 2008

Corindus, Inc. designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s initial product, the CorPath system, provides procedure control from an interventional cockpit, allowing for precise, robotic-assisted placement of coronary guidewires and stent/balloon catheters.

Boards & Committees
Director
Prior - 2009

CytoDome, Inc.manufactures implantable devices for medical treatment. The company provides treatment for diseases of the central nervous system by way of sustained release of therapeutic & diagnostic substances with ever-larger molecules. It was founded by Gill Heart in July, 2003 and is located in Atlanta, GA.

Member, Board of Directors
2001 - 2010

NMT Medical, Inc. is an advanced medical technology company. It designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures. The company was founded in July 1986 and is headquartered in Boston, MA

Chairman & Chief Executive Officer
2000 - 2004
Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
N/A
2007

Boston College is one of the nation's best and most selective universities, with U.S. News & World Report ranking Boston College 31st among national universities, and Forbes ranking it 26th in its 2012 America's Best Colleges listing. Boston College confers more than 4,000 degrees annually in more than 50 fields of study through eight schools and colleges. Faculty members are committed to both teaching and research having earned nearly $60 million in research grants in the last year alone. The University has made a major commitment to academic excellence. As part of its Strategic Plan, Boston College is in the process of adding 100 new faculty positions, expanding faculty and graduate research, increasing student financial aid to more than $128 million annually, and widening opportunities in key undergraduate programs, such as international study, internships and student formation. Boston College has experienced tremendous growth in recent years, including a 75 percent increase in undergraduate applications over the past decade, to more than 34,000 for the 2,250 seats in its freshman class. During the same period, an increase in voluntary giving from alumni has helped to move the University's endowment to approximately $1.9 billion. Boston College students have also earned more than 200 prestigious academic scholarships over the past decade, including 2 Rhodes Scholarships, 4 Marshalls, 9 Goldwaters and 162 Fulbright grants.

Transactions
Details Hidden

NMT Medical, Inc. raised money in a private placement transaction